2014
DOI: 10.1016/j.ijcard.2014.03.075
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular implantable electronic device infective endocarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
7
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(7 citation statements)
references
References 45 publications
0
7
0
Order By: Relevance
“…The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to delivery of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [23][24][25][26][27]. Infectious complications leading also to endocarditis [1,8,[28][29][30][31][32][33][34][35] and non-infectious complications [9,21,23,[36][37][38][39] often necessitating removal [1,2,8,[39][40][41][42][43][44][45] affect patient wellbeing also leading to psychological difficulty increase [46][47][48][49][50][51][52] in the emerging scenario of concomitant problems and diseases . The modern ICDs in the market deliver a maximum energy of 35 to 41 J in relation to the model using single-coil leads or dual-coil leads.…”
mentioning
confidence: 99%
“…The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to delivery of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [23][24][25][26][27]. Infectious complications leading also to endocarditis [1,8,[28][29][30][31][32][33][34][35] and non-infectious complications [9,21,23,[36][37][38][39] often necessitating removal [1,2,8,[39][40][41][42][43][44][45] affect patient wellbeing also leading to psychological difficulty increase [46][47][48][49][50][51][52] in the emerging scenario of concomitant problems and diseases . The modern ICDs in the market deliver a maximum energy of 35 to 41 J in relation to the model using single-coil leads or dual-coil leads.…”
mentioning
confidence: 99%
“…The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to the delivery of pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [23][24][25][26][27]. Infectious complications leading also to endocarditis [1,8,[28][29][30][31][32][33][34][35][36] and non-infectious complications [9,21,23,[37][38][39][40] often necessitating removal [1,2,8,[40][41][42][43][44][45][46] affect patients' wellbeing also leading to psychological difficulties increase [47][48][49][50][51][52][53] in the emerging scenario of concomitant problems and diseases and in patients also needing of device revision and upgrade. Moreover, the modern ICDs in the market deliver maximum energy of 35 to 41 J in relation to the model using single-coil leads or dual-coil leads.…”
mentioning
confidence: 99%
“…The evolution of devices in serious cardiac rhythm pathology management has led progressively to the development of devices for the treatment of bradycardia, ventricular arrhythmia, and heart failure and for the prevention of sudden cardiac arrest leading to delivery of pacemakers, implantable cardioverter defibrillators (ICD)s and cardiac resynchronization therapy (CRT) plus ICD (CRT-D) and to the recent subcutaneous implantable cardioverter-defibrillator (S-ICD) [23][24][25][26][27] and subcutaneous single-finger cardioverter-defibrillator (ICD) system [28]. Infectious complications leading also to endocarditis [1,8,[29][30][31][32][33][34][35][36][37] and non-infectious complications [9,21,23,[38][39][40][41] often necessitating removal [1,2,8,[41][42][43][44][45][46][47] affect patients' wellbeing which also leads to psychological difficulty increase [48][49][50][51][52][53][54] in the emerging scenario of concomitant problems and diseases and in patients that also need device revision and upgrade. In addition, the improved patients' survival, the progressively younger implanted population and the increase in device and procedur...…”
mentioning
confidence: 99%